These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19914720

  • 1. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ, Kauer-Sant'Anna M, Lam RW, Yatham LN.
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [Abstract] [Full Text] [Related]

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Jul; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 3. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C.
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [Abstract] [Full Text] [Related]

  • 4. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
    Kim B, Kim SJ, Son JI, Joo YH.
    J Affect Disord; 2008 Jan; 105(1-3):45-52. PubMed ID: 17498812
    [Abstract] [Full Text] [Related]

  • 5. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jan; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 7. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS.
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [Abstract] [Full Text] [Related]

  • 8. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B.
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [Abstract] [Full Text] [Related]

  • 9. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C.
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [Abstract] [Full Text] [Related]

  • 10. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
    Dikeos D, Badr MG, Yang F, Pesek MB, Fábián Z, Tapia-Paniagua G, Hudiţă C, Okasha T, D'yachkova Y, Harrison G, Treuer T.
    World J Biol Psychiatry; 2010 Jun; 11(4):667-76. PubMed ID: 20334575
    [Abstract] [Full Text] [Related]

  • 11. Atypical antipsychotics related metabolic syndrome in bipolar patients.
    Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, Oral ET, Atagun I.
    J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
    [Abstract] [Full Text] [Related]

  • 12. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.
    Perez-Iglesias R, Mata I, Pelayo-Teran JM, Amado JA, Garcia-Unzueta MT, Berja A, Martinez-Garcia O, Vazquez-Barquero JL, Crespo-Facorro B.
    Schizophr Res; 2009 Feb; 107(2-3):115-21. PubMed ID: 18993033
    [Abstract] [Full Text] [Related]

  • 13. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY, Park MH, Patkar AA, Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):490-6. PubMed ID: 21146575
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E, Goikolea JM.
    Bipolar Disord; 2005 Mar 30; 7 Suppl 4():21-33. PubMed ID: 15948764
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct 30; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

  • 16. Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
    Fraguas D, Merchán-Naranjo J, Laita P, Parellada M, Moreno D, Ruiz-Sancho A, Cifuentes A, Giráldez M, Arango C.
    J Clin Psychiatry; 2008 Jul 30; 69(7):1166-75. PubMed ID: 18588363
    [Abstract] [Full Text] [Related]

  • 17. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project.
    Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I.
    Can J Psychiatry; 2009 Feb 30; 54(2):105-12. PubMed ID: 19254441
    [Abstract] [Full Text] [Related]

  • 18. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M, Bond DJ, Lam RW, Yatham LN.
    Compr Psychiatry; 2009 Feb 30; 50(1):1-8. PubMed ID: 19059506
    [Abstract] [Full Text] [Related]

  • 19. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov 30; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.
    J Affect Disord; 2008 Aug 30; 109(3):251-63. PubMed ID: 18579216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.